Because it degrades in blood in a pathway involving amino-peptidases, it may not be suitable for people who take medications that inhibit or are metabolized by peptidases (e.g., captopril, a treatment for hypertension).4 Also, based on what we know about other therapeutic peptides, we would say DSIP is contraindicated for women who are pregnant or breastfeeding as well as people with a personal history of cancer
Nausea, vomiting, diarrhea, constipation
This approach, which we've refined over years of supplying premier research compounds, is the only way to ensure that the variable being tested is the peptide's effect, not the sloppiness of its preparation
In preclinical models, these mechanisms translate into broad potential applications, including wound healing, muscle and tendon repair, gastrointestinal ulcer protection, and recovery from NSAID-induced damage
Key Features
compounded distinction, and the credibility of the prescriber and pharmacy involved